Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2018

Open Access 01-12-2018 | Research article

Current approaches for the management of Parkinson’s disease in Chinese hospitals: a cross-sectional survey

Authors: Gang Wang, Hai-Lun Cui, Jun Liu, Qin Xiao, Ying Wang, Jian-Fang Ma, Hai-Yan Zhou, Jing Pan, Yu-Yan Tan, Sheng-Di Chen, on behalf of the Chinese Movement Disorders Society

Published in: BMC Neurology | Issue 1/2018

Login to get access

Abstract

Background

Chinese guidelines for management of Parkinson’s disease (PD) have been issued and updated regularly since 2006. We undertook a cross-sectional survey to evaluate the impact of the latest edition (2014) on current approaches to the management of PD based on previous pilot works.

Methods

Seven hundred and seventeen participants, divided into 3 groups (GPs, Neurologists, and Specialists), recruited from 138 randomly chosen hospitals from 30 cities across China, participated by completing the questionnaire describing their current approaches before and after the guidelines were issued.

Results

Considerable discrepancies in management were apparent across the three categories, with different selection of first-choice medication for PD patients. There were also variations in management of concurrent psychiatric symptoms and dementia. Notably, over 50% of participants reported improvements in PD recognition and management by following the guidelines.

Conclusions

The increasing use of Chinese clinical practice guidelines for PD management is having a positive impact on the optimization of care, which in turn offers important economic benefits.
Literature
1.
Wang G, Cheng Q, Zheng R, Tan YY, Sun XK, Zhou HY, Ye XL, Wang Y, Wang Z, Sun BM, et al. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in shanghai, China. Mov Disord. 2006;21(9):1439–43.CrossRefPubMed
2.
Chen SD. The guideline for management of Parkinson's disease in China. Chin J Neurol. 2006;39:409–12.
3.
Chen SD. The guideline for management of Parkinson's disease in China (second edition). Chin J Neurol. 2009;42(5):352–5.
4.
Chen SD. The guideline for management of Parkinson's disease in China (third edition). Chin J Neurol. 2014;47(6):428–33.
5.
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591–601.CrossRefPubMed
6.
Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, Shulman LM, Gronseth G, Weiner WJ. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2006;66(7):996–1002.CrossRefPubMed
7.
Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2006;66(7):983–95.CrossRefPubMed
8.
Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2006;66(7):976–82.CrossRefPubMed
9.
Montgomery EB Jr. Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2007;68(2):164. author reply 164CrossRefPubMed
10.
Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, et al. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol. 2013;20(1):16–34.CrossRefPubMed
11.
Ryton BA, Liddle BJ. Implementing NICE clinical guidelines on Parkinson's disease. Clin Med(Lond). 2009;9(5):436–40.
12.
Chen S, Chan P, Sun S, Chen H, Zhang B, Le W, Liu C, Peng G, Tang B, Wang L, et al. The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease. Transl Neurodegener. 2016;5:12.CrossRefPubMedPubMedCentral
13.
Chen W, Chen S, Xiao Q, Wang G, Chen SD. Current clinical practice for Parkinson's disease among Chinese physicians, general neurologists and movement disorders specialists: a national survey. BMC Neurol. 2012;12:155.CrossRefPubMedPubMedCentral
Metadata
Title
Current approaches for the management of Parkinson’s disease in Chinese hospitals: a cross-sectional survey
Authors
Gang Wang
Hai-Lun Cui
Jun Liu
Qin Xiao
Ying Wang
Jian-Fang Ma
Hai-Yan Zhou
Jing Pan
Yu-Yan Tan
Sheng-Di Chen
on behalf of the Chinese Movement Disorders Society
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2018
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-018-1122-4

Other articles of this Issue 1/2018

BMC Neurology 1/2018 Go to the issue

Research article

Acquired modification of sphingosine-1-phosphate lyase activity is not related to adrenal insufficiency

Research article

The clinical assessment of amyotrophic lateral sclerosis patients’ prognosis by ZNF512B gene, neck flexor muscle power score and body mass index (BMI)

Research article

Re-evaluation of the stroke prognostication using age and NIH Stroke Scale index (SPAN-100 index) in IVT patients — the-SPAN 10065 index

Case report

Rheumatoid meningitis presenting with a stroke-like attack treated with recombinant tissue plasminogen activator: a case presentation

Case report

Case series of Creutzfeldt-Jakob disease in a third-level hospital in Quito

Research article

Do fragments and glycosylated isoforms of alpha-1-antitrypsin in CSF mirror spinal pathophysiological mechanisms in chronic peripheral neuropathic pain? An exploratory, discovery phase study